Tag Archive: funding

May 02

Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry

Over the past 5 years, the life sciences industry throughout Canada, and especially in Québec, has been extensively challenged. Capitalizing on strong relationships built over years with clients and partners has helped Cato Research continue to provide excellent services and weather the industry’s roller coaster ride. On 03 May 2012, Cato Research Canada will celebrate its 20th anniversary with a celebratory wine tasting. You are invited to join us and other industry representatives to talk about the changing climate for pharmaceutical and biotechnology companies in Canada.

Feb 23

The CED Life Science Conference and Biotech’s Yellow Brick Road

The 21st annual CED Life Science Conference achieved its mission of cementing the Research Triangle Park as a hotbed for innovation and opportunity in biotech.  The 2012 CED LSC showcased local leaders like Victor Dzau, President and CEO of Duke University Health Systems, and former four-term North Carolina governor James B. Hunt, as well as …

Continue reading »

Jun 28

Biotech Funding: Still Playing Hard-to-Get

After a few lean years, biotechs raised $25 billion in 2010.  For the majority of small companies however, funding remains difficult to find.  Ernst & Young’s annual report on the biotechnology industry, Beyond Borders, was recently released and it paints a less rosy picture than the $25 billion number would appear to. It turns out …

Continue reading »

May 27

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

Bridge

To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  However, it is doable, and one can point to successful biotechs such as Genentech, Amgen, …

Continue reading »

May 11

Conference Recap – BayBio 2011

The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA.  The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on funding trends and emerging markets in the life sciences industry.  In keeping with BayBio’s spirit …

Continue reading »

Feb 28

Recap of the 20th CED Biotech/Life Sciences Conference

The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina.

Oct 26

Vendor Selection – All that Glitters is Not Gold

One of the most important, and difficult, decisions a company has to make is selecting the right contract research organization (CRO) for outsourcing its nonclinical, manufacturing, clinical and regulatory activities.  Several variables determine what makes a good outsourcing partner – size compatibility between CRO and sponsor, the cost, and the experience level of the CRO …

Continue reading »

Mar 31

Cato Sponsors BayBio 2010 Conference

BayBio will be holding it’s annual conference, BayBio 2010, on Wednesday, 07 April 2010 at the Hyatt Regency San Francisco Airport in Burlingame, California.  This year’s conference will examine the fundamental questions of who pays for biotech innovation and why in this unprecedented environment.   It will focus on how the current financing environment and new …

Continue reading »

Feb 16

Show Me Where Else The Money Isv

Today we feature a post on funding for small biotech and pharma by Dr. Tariq Allana.  Tariq is a Clinical Strategy Scientist at Cato Research and the Associate Director of Business Development. Developing a comprehensive and creative clinical and regulatory development strategy for getting one’s product from the bench to the bedside is challenging enough …

Continue reading »